Market Overview

Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue

Related HSP
BioScrip Posts Wider-than-Expected Q2 Loss on Poor Margins
Hospira Inc. (HSP) Jumps: Stock Adds 8.3% in Session - Tale of the Tape
Related VRX
Benzinga's M&A Chatter for Tuesday August 19, 2014
Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs
Allergan Rebuffs Valeant's Tender Offer (Fox Business)

Below are the top drug delivery stocks on the NYSE in terms of revenue.

The trailing-twelve-month revenue at Hospira (NYSE: HSP) is $4.02 billion. Hospira had $655.90 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Valeant Pharmaceuticals International (NYSE: VRX) is $2.75 billion. Valeant Pharmaceuticals' operating margin for the same period is 23.99%.

The trailing-twelve-month revenue at Elan Corporation plc (NYSE: ELN) is $1.29 billion. Elan's ROE for the same period is 102.84%.

The trailing-twelve-month revenue at K-V Pharmaceutical Company (NYSE: KV-A) is $23.20 million. K-V Pharmaceutical had $50.70 million in total cash for the latest quarter.

Posted-In: Drug Delivery Industry Highest Revenue NYSETrading Ideas

 

Most Popular

Related Articles (ELN + HSP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters